289 related articles for article (PubMed ID: 24098676)
1. Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model.
Shen F; Tsuruda PR; Smith JA; Obedencio GP; Martin WJ
PLoS One; 2013; 8(9):e74891. PubMed ID: 24098676
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D(1) and D(2) receptor agonism enhances antinociception mediated by the serotonin and noradrenaline reuptake inhibitor duloxetine in the rat formalin test.
Munro G
Eur J Pharmacol; 2007 Dec; 575(1-3):66-74. PubMed ID: 17725928
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys.
Gatch MB; Negus SS; Mello NK
Psychopharmacology (Berl); 1998 Jan; 135(1):99-106. PubMed ID: 9489939
[TBL] [Abstract][Full Text] [Related]
4. Preclinical to clinical translation of CNS transporter occupancy of TD-9855, a novel norepinephrine and serotonin reuptake inhibitor.
Smith JA; Bourdet DL; Daniels OT; Ding YS; Gallezot JD; Henry S; Kim KH; Kshirsagar S; Martin WJ; Obedencio GP; Stangeland E; Tsuruda PR; Williams W; Carson RE; Patil ST
Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522383
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain.
Gould GG; Javors MA; Frazer A
Biol Psychiatry; 2007 Jan; 61(2):210-5. PubMed ID: 16650830
[TBL] [Abstract][Full Text] [Related]
6. Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.
Béïque JC; Lavoie N; de Montigny C; Debonnel G
Eur J Pharmacol; 1998 May; 349(1):129-32. PubMed ID: 9669506
[TBL] [Abstract][Full Text] [Related]
7. AS1069562, the (+)-isomer of indeloxazine, exerts analgesic effects in a rat model of neuropathic pain with unique characteristics in spinal monoamine turnover.
Murai N; Aoki T; Tamura S; Sekizawa T; Kakimoto S; Tsukamoto M; Oe T; Enomoto R; Hamakawa N; Matsuoka N
J Pharmacol Exp Ther; 2014 Mar; 348(3):372-82. PubMed ID: 24338505
[TBL] [Abstract][Full Text] [Related]
8. The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor.
Jin ZL; Gao N; Zhou D; Chi MG; Yang XM; Xu JP
Pharmacol Biochem Behav; 2012 Jan; 100(3):431-9. PubMed ID: 22005599
[TBL] [Abstract][Full Text] [Related]
9. Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats.
Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
J Neurochem; 1997 Dec; 69(6):2616-9. PubMed ID: 9375697
[TBL] [Abstract][Full Text] [Related]
10. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.
Bymaster FP; Dreshfield-Ahmad LJ; Threlkeld PG; Shaw JL; Thompson L; Nelson DL; Hemrick-Luecke SK; Wong DT
Neuropsychopharmacology; 2001 Dec; 25(6):871-80. PubMed ID: 11750180
[TBL] [Abstract][Full Text] [Related]
11. Effects of duloxetine on norepinephrine and serotonin transporter activity in healthy subjects.
Chappell JC; Eisenhofer G; Owens MJ; Haber H; Lachno DR; Dean RA; Knadler MP; Nemeroff CB; Mitchell MI; Detke MJ; Iyengar S; Pangallo B; Lobo ED
J Clin Psychopharmacol; 2014 Feb; 34(1):9-16. PubMed ID: 24346757
[TBL] [Abstract][Full Text] [Related]
12. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
Koch S; Hemrick-Luecke SK; Thompson LK; Evans DC; Threlkeld PG; Nelson DL; Perry KW; Bymaster FP
Neuropharmacology; 2003 Dec; 45(7):935-44. PubMed ID: 14573386
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME
PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
Iyengar S; Webster AA; Hemrick-Luecke SK; Xu JY; Simmons RM
J Pharmacol Exp Ther; 2004 Nov; 311(2):576-84. PubMed ID: 15254142
[TBL] [Abstract][Full Text] [Related]
15. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
Xie Z; Westmoreland SV; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
[TBL] [Abstract][Full Text] [Related]
16. Prediction of human serotonin and norepinephrine transporter occupancy of duloxetine by pharmacokinetic/pharmacodynamic modeling in the rat.
Bourdet DL; Tsuruda PR; Obedencio GP; Smith JA
J Pharmacol Exp Ther; 2012 Apr; 341(1):137-45. PubMed ID: 22235148
[TBL] [Abstract][Full Text] [Related]
17. An investigation of monoamine receptors involved in antinociceptive effects of antidepressants.
Yokogawa F; Kiuchi Y; Ishikawa Y; Otsuka N; Masuda Y; Oguchi K; Hosoyamada A
Anesth Analg; 2002 Jul; 95(1):163-8, table of contents. PubMed ID: 12088962
[TBL] [Abstract][Full Text] [Related]
18. Diffuse noxious inhibitory controls and nerve injury: restoring an imbalance between descending monoamine inhibitions and facilitations.
Bannister K; Patel R; Goncalves L; Townson L; Dickenson AH
Pain; 2015 Sep; 156(9):1803-1811. PubMed ID: 26010460
[TBL] [Abstract][Full Text] [Related]
19. Serotonin and norepinephrine transporter binding profile of SSRIs.
Gutman DA; Owens MJ
Essent Psychopharmacol; 2006; 7(1):35-41. PubMed ID: 16989291
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic and acute administration of fluoxetine and its additive effect with morphine on the behavioural response in the formalin test in rats.
Nayebi AR; Hassanpour M; Rezazadeh H
J Pharm Pharmacol; 2001 Feb; 53(2):219-25. PubMed ID: 11273019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
